Will Reducing or Discontinuing Diazepam Improve Ataxia and Unsteady Gait?
Yes, gradually tapering and discontinuing diazepam will very likely improve your ataxia and unsteady gait, as benzodiazepines—especially long-acting agents like diazepam—are a well-established cause of motor impairment, falls, and gait instability in older adults. 1, 2, 3
Why Diazepam Causes Ataxia and Gait Problems
Diazepam is classified as a high-risk medication for patients ≥65 years by the American Geriatrics Society Beers Criteria because it increases sedation, cognitive impairment, unsafe mobility (fall risk), and motor-skill deficits. 1, 2
Long-acting benzodiazepines like diazepam accumulate due to their prolonged half-life, leading to enhanced CNS depression that directly impairs cerebellar and motor coordination. 2
Drug-induced cerebellar ataxia from benzodiazepines is well-documented and commonly reversible after discontinuation; benzodiazepines are among the most frequent drug classes causing ataxia as an adverse drug reaction. 3
The FDA label explicitly warns that diazepam has central nervous system depressant effects that impair motor function, and the label emphasizes gradual tapering to discontinue the medication safely. 4
Expected Improvement After Discontinuation
In most patients, ataxia symptoms occur within days or weeks after starting a benzodiazepine or increasing the dose, and they tend to disappear after discontinuation of the drug. 3
Stopping diazepam removes the ongoing CNS depressant effect, which should restore normal cerebellar function, improve coordination, and reduce fall risk. 1, 2
Persistent ataxia after benzodiazepine discontinuation is uncommon; chronic ataxia has been described primarily with lithium and certain antineoplastics, not typically with benzodiazepines. 3
How to Safely Taper Diazepam
Critical Safety Warning
- Abrupt discontinuation must be avoided because it can precipitate life-threatening withdrawal complications including rebound anxiety, hallucinations, seizures, delirium tremens, and rarely death. 2, 4
Recommended Tapering Schedule
For older adults (≥65 years) or patients with ≥1 year of continuous benzodiazepine use, reduce the dose by approximately 10% per month or slower to improve tolerability and limit withdrawal symptoms. 2
A patient-specific gradual taper plan should be used, as mandated by the FDA label; if withdrawal symptoms emerge, pause the taper or slow it further rather than restarting the previous dose without reassessment. 2, 4
Monthly follow-up visits are the minimum requirement during tapering, with more frequent contact (telephone, telehealth, or in-person) if withdrawal symptoms appear. 2
Monitoring During the Taper
Close monitoring for withdrawal symptoms is essential: watch for anxiety, insomnia, tremor, autonomic instability, and any worsening of ataxia (which may transiently occur during withdrawal before improvement). 2, 4
The overall taper duration may extend from several months to over a year for older adults with long-term benzodiazepine use; this extended timeline should be discussed at the outset. 2
Adjunctive Strategies to Support Discontinuation
Cognitive-behavioral therapy (CBT) markedly improves taper success and should be offered alongside the medication reduction plan. 2
Patient education combined with a gradual taper achieved a 27% discontinuation rate versus 5% in usual-care controls in the high-quality EMPOWER trial, providing strong evidence for an educational-behavioral approach. 2
Alternative non-benzodiazepine treatments for anxiety and insomnia—such as SSRIs/SNRIs, sleep-hygiene measures, relaxation techniques, and behavioral interventions—should be offered to address the underlying indication for which diazepam was prescribed. 2
Common Pitfalls to Avoid
Do not use diazepam as a "tapering agent" in elderly patients; switching from another benzodiazepine to diazepam contradicts geriatric prescribing guidelines and may worsen adverse events in this age group. 2
Do not abandon the patient if tapering proves difficult; schedule regular follow-up visits and provide ongoing multidisciplinary support (nurses, pharmacists, behavioral health). 2
Do not restart the previous dose without reassessment when withdrawal symptoms emerge; instead, pause or slow the taper and consider adjunctive support. 2
Bottom Line
Discontinuing diazepam through a slow, supervised taper will very likely resolve your ataxia and unsteady gait, as these symptoms are direct adverse effects of benzodiazepine CNS depression. The key is to taper gradually (approximately 10% per month in older adults), monitor closely for withdrawal, and provide behavioral support to maximize success and safety. 2, 4, 3